Here's How Much $100 Invested In Cytokinetics 10 Years Ago Would Be Worth Today
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 7.02% on an annualized basis producing an average annual return of 20.46%. Currently, Cytokinetics has a market capitalization of $10.71
Cytokinetics stock grew much faster than the overall market over ten years, making early investors a lot of money. When a company's stock does really well for a long time, it shows people believe in what it does—but past wins don't promise future ones.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.